June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Inner Retinal Oxygen Metabolism and Delivery in Streptozotocin Diabetic Rats
Author Affiliations & Notes
  • Justin Wanek
    Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • Pang-yu Teng
    Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • Norman Blair
    Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • Mahnaz Shahidi
    Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • Footnotes
    Commercial Relationships Justin Wanek, None; Pang-yu Teng, None; Norman Blair, None; Mahnaz Shahidi, Patent (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4886. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Justin Wanek, Pang-yu Teng, Norman Blair, Mahnaz Shahidi; Inner Retinal Oxygen Metabolism and Delivery in Streptozotocin Diabetic Rats. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4886.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Diabetic retinopathy is a vision threatening disease causing alterations in the retinal vasculature that likely impair the supply and utilization of oxygen. The purpose of this study is to report for the first time measurements of inner retinal oxygen metabolism (MO2) and delivery (DO2) by combined oxygen tension (PO2) and blood flow imaging in a streptozotocin (STZ) rat model of diabetes.

Methods: Imaging was performed in diabetic rats (N = 8) four weeks after intravenous injection of STZ (60 mg/kg) and in healthy control rats (N = 10). PO2 in all major retinal arteries and veins was measured using a previously established phosphorescence lifetime imaging system and converted to arterial (O2A) and venous (O2V) oxygen contents, respectively. Blood velocity was determined by imaging the intravascular motion of fluorescent microspheres and venous diameter was measured from red-free retinal images, allowing calculation of blood flow in each vein. Total retinal venous blood flow (F) was determined by summing blood flows in all veins. Inner retinal MO2 was assessed based on the product of F and the arteriovenous oxygen content difference and DO2 was calculated from the product of F and O2A, based on Fick’s principle. Unpaired Student’s t-test and ANCOVA that adjusted for variability due to DO2 were used for statistical comparison.

Results: Rats injected with STZ had blood glucose levels of 398 ± 56 mg/dL, confirming the presence of diabetes. As compared to control rats, O2A in diabetic rats was similar (p = 0.2) and O2V was significantly higher (p = 0.02). The arteriovenous oxygen content difference and F were not significantly different between diabetic and control rats (p ≥ 0.3). Inner retinal DO2 in diabetic (1011 ± 193 nL O2/min) and control (941 ± 231 nL O2/min) rats were comparable (p = 0.5). Likewise, inner retinal MO2 in diabetic (442 ± 62 nL O2/min) and control (516 ± 175 nL O2/min) rats were similar (p = 0.3). After adjusting for variability due to DO2, MO2 was significantly lower in diabetic rats as compared to control rats (p = 0.03).

Conclusions: For given levels of oxygen delivery, a significant reduction in inner retinal MO2 was established in diabetic rats, suggesting alterations in the retinal energy metabolism early in the disease progression.

Keywords: 551 imaging/image analysis: non-clinical • 635 oxygen • 499 diabetic retinopathy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×